Related Experiment Video
Updated: Jun 3, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Innovative approaches to clinical development and trial design
John J Orloff1, Donald Stanski
1Novartis Pharma AG, One Health Plaza, East Hanover, NJ 07936-1080, USA. john.orloff@novartis.com
Annali Dell'Istituto Superiore Di Sanita
|March 25, 2011
Summary
Novel clinical trial designs enhance pharmaceutical R&D efficiency and reduce attrition. Innovative methods like adaptive trials and Bayesian statistics improve drug development despite challenges.
Area of Science:
- Pharmaceutical R&D
- Clinical Trial Design
- Biostatistics
Background:
- Pharmaceutical innovation faces declining productivity due to increased risks and costs.
- Despite higher R&D investment, the number of new molecular entities (NMEs) approved has not increased.
- Current clinical development models struggle with efficiency and high attrition rates.
Purpose of the Study:
- To explore novel approaches in clinical development and trial design to enhance efficiency and reduce attrition.
- To highlight the role of integrated models and innovative tools in overcoming pharmaceutical R&D challenges.
- To discuss the application, advantages, and barriers of novel methodologies in drug development.
Main Methods:
- Review of novel tools including modeling and simulation, Bayesian methodologies, and adaptive trial designs.
- Description of applications in early- and late-stage drug development with specific examples.
- Analysis of advantages, challenges, and barriers to the implementation of innovative designs.
Main Results:
- Innovative trial designs offer flexibility and maximize knowledge utilization, improving clinical development effectiveness.
- Methodologies like seamless adaptive designs and sample-size re-estimation can reduce attrition rates.
- These flexible designs require robust statistical analysis and planning, necessitating more time for protocol development.
Conclusions:
- Novel clinical trial designs are crucial for improving pharmaceutical R&D efficiency and productivity.
- Wider adoption of innovative designs requires greater awareness and understanding from regulators and sponsors.
- Overcoming implementation barriers is key to leveraging advanced statistical and logistical approaches in drug development.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...